by James Dye | Feb 21, 2024 | Press Releases
LEHI, Utah, Feb. 21, 2024 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced that David J. Bearss, Ph.D., President and CEO of... by James Dye | Feb 15, 2024 | Press Releases
The first patient undergoing wisdom tooth extraction has been dosed with HT-6184 to evaluate its effect on post-procedure diagnostic biomarkers of inflammation and pain, as well as to evaluate its safety and tolerability. LEHI, Utah, Feb. 15, 2024 /PRNewswire/... by James Dye | May 20, 2022 | News & Media
by Jeremie Oliver May 20, 2022 For Utah Business, I’ve covered biotechnology breakthroughs ranging from breast cancer diagnosis to novel intestinal disease therapeutics. But we haven’t yet discussed a disease that is even more prevalent than those combined:... by James Dye | Dec 2, 2017 | News & Media
Published: Dec 2, 2017, at 5:20 p.m. By Deseret News PROVO — A new way to examine Alzheimer’s disease has provided a tantalizing potential treatment approach to prevent the devastating condition, according to BYU-led research published online in the...